It has also been described that treatment with HIF1α-inhibitor significantly improved IFN-α/β synthesis, in turn decreasing viral infections in EGLN1c.[12C>G;380G>C] (PHD2D4E;C127S) cells in vitro. Here, HIF1A is linked to viral infectious disease.